Metabotropic Glutamate Receptor 7 (mGluR7) Neurons

Metabotropic Glutamate Receptor 7 (mGluR7) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Metabotropic Glutamate Receptor 7 (mGluR7) Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus CA3</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Dentate Gyrus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Olfactory Bulb</td>
<td>High</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Type</td>
</tr>
<tr>
<td class="label">AMN082</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">ADX71743</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">DSP-0046</td>
<td>PAM</td>
</tr>
<tr>
<td class="label">MMPIP</td>
<td>Antagonist</td>
</tr>
<tr>
<td class="label">VU6015728</td>
<td>PAM</td>
</tr>
</table>

Metabotropic Glutamate Receptor 7 (mGluR7) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Metabotropic Glutamate Receptor 7 (mGluR7) Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus CA3</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Dentate Gyrus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Olfactory Bulb</td>
<td>High</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Type</td>
</tr>
<tr>
<td class="label">AMN082</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">ADX71743</td>
<td>Agonist</td>
</tr>
<tr>
<td class="label">DSP-0046</td>
<td>PAM</td>
</tr>
<tr>
<td class="label">MMPIP</td>
<td>Antagonist</td>
</tr>
<tr>
<td class="label">VU6015728</td>
<td>PAM</td>
</tr>
</table>

Related Diseases: [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Epilepsy](/diseases/epilepsy)

Related Pathways: [Glutamate Signaling](/mechanisms/glutamate-signaling), [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction), [Excitotoxicity](/mechanisms/excitotoxicity)

Related Proteins: [Tau](/proteins/tau), [Alpha-Synuclein](/proteins/alpha-synuclein), [GRM7](/proteins/grm7-protein)

Related Cell Types: [Hippocampal Neurons](/cell-types/hippocampal-neurons), [Basal Ganglia Neurons](/cell-types/basal-ganglia-neurons), [Microglia](/cell-types/microglia)

Metabotropic Glutamate Receptor 7 (mGluR7) Neurons in Neurodegeneration

Overview

Metabotropic Glutamate Receptor 7 (Mglur7) Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Introduction

Metabotropic glutamate receptor 7 (mGluR7) is a Group III metabotropic glutamate receptor with the highest affinity for glutamate among mGluRs, functioning as a synaptic "glutamate sensor" that prevents synaptic overflow. It is widely expressed throughout the brain, particularly in the hippocampus, cortex, amygdala, basal ganglia, and brainstem. mGluR7 has emerged as a promising therapeutic target for epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological disorders due to its role in modulating synaptic transmission and neuronal excitability [1](https://pubmed.ncbi.nlm.nih.gov/10908610/). [@kinoshita1998]

Molecular Properties

Gene and Protein Structure

• Gene: GRM7 (glutamate metabotropic receptor 7), located on chromosome 1p31.1
• Protein: 877 amino acids, class C GPCR with large extracellular Venus flytrap domain
• Isoforms: Multiple splice variants (mGluR7a, mGluR7b) with distinct subcellular distributions
• Alternative names: GLUR7, mGlu7, GRM7

Signaling Mechanisms

• G protein coupling: Primarily Gi/o-coupled, inhibits adenylate cyclase
• cAMP reduction: Decreases intracellular cAMP levels
• Ion channel modulation: Can inhibit voltage-gated calcium channels (N-type, P/Q-type)
• K+ channel activation: Promotes neuronal hyperpolarization

Receptor Distribution

• Presynaptic localization: Predominantly on presynaptic terminals, especially at excitatory synapses
• Postsynaptic expression: Lower levels on dendritic shafts and spines
• Brain regional expression: Highest in hippocampus (CA3, dentate gyrus), olfactory bulb, cerebral cortex, basal ganglia, and brainstem nuclei [2](https://pubmed.ncbi.nlm.nih.gov/10908610/)

Synaptic Physiology

Glutamate Sensing

mGluR7 acts as a high-affinity glutamate sensor: [@marti2002]

• Low basal activity: Active only at higher glutamate concentrations
• Phasic activation: Responds to synaptic glutamate release during high-frequency firing
• Transient response: Rapid desensitization limits prolonged signaling

Synaptic Plasticity

• LTPmechanisms/long-term-potentiation) modulation: mGluR7 activation impairs hippocampal CA1 LTP [3](https://pubmed.ncbi.nlm.nih.gov/10908610/)
• LTD induction: Facilitates NMDA receptor-dependent LTD
• Presynaptic plasticity: Regulates probability of neurotransmitter release

Neuromodulation

mGluR7 interacts with other transmitter systems: [@mitsukawa2005]

• Dopaminergic modulation: Modulates striatal dopamine release
• Serotonergic interaction: 5-HT influences mGluR7 function
• GABAergic effects: Bidirectional modulation of inhibition

Role in Neurodegenerative Diseases

Epilepsy

mGluR7 is critically involved in seizure pathophysiology: [@julius2009]

Alzheimer's Disease

mGluR7 dysregulation contributes to AD pathology: [@niswender2010]

• Amyloid interaction: Aβ oligomers reduce mGluR7 expression and function
• Tau pathology: Hyperphosphorylated tau affects mGluR7 trafficking
• Memory impairment: mGluR7 knockout mice show deficits in spatial memory [5](https://pubmed.ncbi.nlm.nih.gov/20531391/)
• Synaptic loss: mGluR7 dysfunction contributes to synaptic failure

Parkinson's Disease

mGluR7 plays complex roles in PD: [@mitsukawa2005a]

• Dopaminergic modulation: Regulates dopamine release in the striatum
• Motor control: Altered mGluR7 signaling contributes to parkinsonian symptoms
• Levodopa-induced dyskinesias: mGluR7 antagonists may reduce dyskinesias [6](https://pubmed.ncbi.nlm.nih.gov/19730416/)
• Neuroprotection: mGluR7 activation may protect dopaminergic neurons

Other Disorders

• Anxiety and depression: mGluR7 in amygdala and prefrontal cortex modulates emotional processing
• Autism spectrum disorders: GRM7 polymorphisms associated with ASD risk
• Fragile X syndrome: mGluR7 dysfunction contributes to synaptic defects
• Huntington's disease: Altered mGluR7 expression in striatum and cortex

Therapeutic Targeting

Agonists

• AMN082: First selective mGluR7 allosteric agonist, but with limited brain penetration [7](https://pubmed.ncbi.nlm.nih.gov/15857679/)
• ADX71743: Potent mGluR7 agonist with better pharmacokinetic properties
• Clinical potential: Anti-seizure, anxiolytic, and cognitive-enhancing effects

Positive Allosteric Modulators (PAMs)

• DSP-0046: Brain-penetrant mGluR7 PAM under development
• Advantages over agonists: Preserve receptor signaling temporal dynamics

Antagonists

• MMPIP: Selective mGluR7 antagonist
• Potential applications: May reduce levodopa-induced dyskinesias in PD

Gene Therapy

• Viral vector delivery: AAV-mediated GRM7 overexpression under investigation
• Antisense oligonucleotides: Targeting GRM7 mRNA for allele-specific knockdown

Molecular Mechanisms of Dysfunction

Genetic Factors

• GRM7 polymorphisms: Associated with epilepsy, ASD, and depression risk
• Copy number variations: GRM7 duplications/deletions in neurodevelopmental disorders
• Epigenetic regulation: DNA methylation affects GRM7 expression

Protein Trafficking

• PICK1 interaction: Protein interacting with C-kinase 1 regulates mGluR7 trafficking
• GRIP1/GRIP2: Scaffold proteins for receptor localization
• Synaptic targeting defects: Common in neurodegeneration

Signaling Dysregulation

• cAMP pathway: Altered downstream signaling in disease states
• Calcium dysregulation: Impaired calcium handling affects receptor function
• ERK/MAPK activation: Abnormal activation in epilepsy and AD

Summary

mGluR7 represents a critical glutamatergic signaling hub that modulates synaptic transmission throughout the brain. Its high affinity for glutamate makes it uniquely positioned to sense synaptic activity and prevent excitotoxicity. Dysregulation of mGluR7 contributes to epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological conditions. Developing selective mGluR7 modulators holds promise for treating these disorders, though challenges remain in achieving brain-penetrant compounds with appropriate pharmacokinetics.

Additional Molecular Mechanisms and Therapeutic Developments

Detailed Signaling Pathways

mGluR7 activation triggers multiple downstream signaling cascades that are critical for understanding its role in neurodegeneration [@sansi2015]:

Primary Signaling Cascade:

• Gαi/o activation: Gi/o protein-coupled inhibition of adenylate cyclase
• cAMP reduction: Decreased intracellular cAMP leads to reduced PKA activity
• Ion channel modulation: Inhibition of voltage-gated calcium channels (N-type, P/Q-type) reduces Ca²⁺ influx
• K⁺ channel activation: Activation of G-protein-gated inwardly rectifying K⁺ (GIRK) channels promotes neuronal hyperpolarization

• MAPK pathway: mGluR7 activation can modulate ERK1/2 signaling in a context-dependent manner
• PI3K/Akt pathway: Neuroprotective signaling through Akt phosphorylation
• PLCβ activation: Some mGluR7 splice variants can couple to PLCβ, generating IP₃ and DAG

mGluR7 in Excitotoxicity

Excitotoxicity is a key mechanism in neurodegenerative diseases, and mGluR7 plays a protective role against glutamate-induced neuronal damage [@favaron2010] [@valenti2002]:

Brain Region-Specific Expression

Detailed mapping of mGluR7 distribution reveals region-specific expression patterns [@ohishi1998a] [@ohishi1998b] [@corti2007]:

Synaptic Plasticity Mechanisms

mGluR7 plays complex roles in both long-term potentiation (LTP) and long-term depression (LTD) [@lazdowsky2019] [@fischer2010]:

LTP Modulation:

• mGluR7 activation during high-frequency stimulation can impair hippocampal CA1 LTP
• The mechanism involves inhibition of cAMP/PKA signaling required for LTP induction
• Presynaptic mGluR7 regulates neurotransmitter release probability during LTP

• mGluR7 facilitates NMDA receptor-dependent LTD
• Lower threshold for LTD induction in the presence of mGluR7 agonists
• Internalization of AMPA receptors accompanies mGluR7-mediated LTD

Therapeutic Modulators in Development

Despite challenges in developing brain-penetrant mGluR7 modulators, several compounds have shown promise [@brIDGETT2016]:

Genetic Insights and Polymorphisms

GRM7 polymorphisms have been linked to various neurological conditions [@molyneux2004]:

• Epilepsy risk: Specific GRM7 variants associated with increased seizure susceptibility
• Autism spectrum disorders: GRM7 polymorphisms found in ASD patients
• Depression: GRM7 variants linked to major depressive disorder
• Cognitive function: GRM7 alleles influence cognitive performance in humans
• Alcohol dependence: GRM7 variants associated with alcohol use disorder

Neuroinflammation and mGluR7

Recent studies have revealed connections between mGluR7 and neuroinflammation [@wang2020]:

• Microglial modulation: mGluR7 expressed on microglia can modulate inflammatory responses
• Cytokine regulation: mGluR7 activation can alter pro-inflammatory cytokine release
• Neuroprotection: mGluR7-mediated signaling can protect neurons from inflammation-induced damage
• Therapeutic implications: Targeting mGluR7 may provide anti-inflammatory effects in neurodegenerative diseases

mGluR7 in Alzheimer's Disease: Detailed Mechanisms

mGluR7 dysregulation contributes to AD pathology through multiple mechanisms [@boscia2016] [@caccamo2016]:

mGluR7 in Parkinson's Disease: Detailed Mechanisms

mGluR7 plays complex roles in PD pathophysiology and treatment [@gu2012] [@kinoshita2018] [@ibayashi2019]:

Future Research Directions

Key questions remain about mGluR7 function and therapeutic potential:

Cross-Linking to Related Topics

• [Glutamate Signaling](/mechanisms/glutamate-signaling) — Overview of glutamatergic neurotransmission
• [Excitotoxicity](/mechanisms/excitotoxicity) — Glutamate-induced neuronal damage
• [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction) — Synaptic failure mechanisms
• [GRM7 Gene](/genes/grm7) — Gene encoding mGluR7
• [GRM7 Protein](/proteins/grm7-protein) — Protein product
• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD overview
• [Parkinson's Disease](/diseases/parkinsons-disease) — PD overview
• [Epilepsy](/diseases/epilepsy) — Seizure disorders

References

• Metabotropic Glutamate Receptor 7 — mGluR7 receptor
• Glutamate Receptors — Excitatory neurotransmission
• Presynaptic Terminal — Synaptic transmission
• Hypothalamus — Brain region

External Links

• [IUPHAR: mGluR7](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=206)
• [UniProt: Q14816](https://www.uniprot.org/uniprot/Q14816)
• [GeneCards: GRM7](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRM7)
• [NCBI Gene: 2917](https://www.ncbi.nlm.nih.gov/gene/2917)